These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6426780)

  • 21. In vitro and in vivo anti-tumor effects of Astragalus membranaceus.
    Cho WC; Leung KN
    Cancer Lett; 2007 Jul; 252(1):43-54. PubMed ID: 17223259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell-macrophage cognate interaction in the activation of macrophage effector function by Th2 cells.
    Stout RD; Suttles J
    J Immunol; 1993 Jun; 150(12):5330-7. PubMed ID: 8515061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of the strength of cell-cell adhesion: the capture of tumor cells by activated murine macrophages proceeds through two distinct stages.
    Somers SD; Whisnant CC; Adams DO
    J Immunol; 1986 Feb; 136(4):1490-6. PubMed ID: 3080524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages.
    Mitani M; Matsumoto T; Mori K; Miake S; Himeno K; Nomoto K
    J Clin Lab Immunol; 1985 Oct; 18(2):97-101. PubMed ID: 3935795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple tumoricidal effector mechanisms induced by adriamycin.
    Salazar D; Cohen SA
    Cancer Res; 1984 Jun; 44(6):2561-6. PubMed ID: 6327018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor cytokinetics in the presence of normal, alloimmune, or Bacillus Calmette-Guérin-activated host cells simultaneously assayed in vivo and in vitro.
    Normann SJ; Cornelius J
    Cancer Res; 1987 Apr; 47(8):2067-72. PubMed ID: 3828996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of macrophage tumoricidal activity by photodynamic treatment in vitro--indirect activation of macrophages by photodynamically killed tumor cells.
    Reiter I; Schwamberger G; Krammer B
    J Photochem Photobiol B; 1999 Jun; 50(2-3):99-107. PubMed ID: 10515075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influences of inflammatory macrophages on the proliferation of mouse tumor cells in vitro].
    Sun DM; Hu XZ; Shi W; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):247-9. PubMed ID: 3093180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmentation of an antitumor CTL response In vivo by inhibition of suppressor macrophage nitric oxide.
    Medot-Pirenne M; Heilman MJ; Saxena M; McDermott PE; Mills CD
    J Immunol; 1999 Dec; 163(11):5877-82. PubMed ID: 10570272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of macrophage-mediated cytotoxicity: production of a soluble cytotoxic factor.
    Drysdale BE; Zacharchuk CM; Shin HS
    J Immunol; 1983 Nov; 131(5):2362-7. PubMed ID: 6415164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taxol provides a second signal for murine macrophage tumoricidal activity.
    Manthey CL; Perera PY; Salkowski CA; Vogel SN
    J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purified human macrophage secretions suppress tumor growth in the mouse.
    Cameron DJ
    J Reticuloendothel Soc; 1983 Jul; 34(1):45-52. PubMed ID: 6410064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
    Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
    Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
    Johnson WJ; Whisnant CC; Adams DO
    J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutting edge: differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities.
    Reiter I; Krammer B; Schwamberger G
    J Immunol; 1999 Aug; 163(4):1730-2. PubMed ID: 10438900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of macrophages for tumor cell cytotoxicity: identification of indomethacin sensitive and insensitive pathways.
    Drysdale BE; Shin HS
    J Immunol; 1981 Aug; 127(2):760-5. PubMed ID: 6788847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of macrophage activity by 12-O-tetradecanoylphorbol-13-acetate.
    Gemsa D; Staar U; Grimm W; Hausmann G; Körner CF; Resch K; Krammer PH
    IARC Sci Publ; 1984; (56):319-36. PubMed ID: 6085623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo cisplatin-exposed macrophages increase immunostimulant-induced nitric oxide synthesis for tumor cell killing.
    Son K; Kim YM
    Cancer Res; 1995 Dec; 55(23):5524-7. PubMed ID: 7585626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
    Vallera DA; Taylor PA; Aukerman SL; Blazar BR
    Cancer Res; 1993 Sep; 53(18):4273-80. PubMed ID: 8364923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.